The Hepatic Fibrosis Laboratory investigates the cellular and molecular mechanisms of scar tissue formation in the liver. This leads to fibrosis and cirrhosis in adult liver diseases such as haemochromatosis and in children in diseases such as cystic fibrosis and biliary atresia.
Group Leader: Professor Grant Ramm
- Dr Manuel Fernandez-Rojo, Visiting Scientist
- Dr Anita Burgess, Research Officer
- Louise Ramm, Research Assistant
- Diem Hoang-Le, Research Assistant
- Michael Pearen, Research Officer
- Emeritus Professor Ross Shepherd, Visiting Scientist
- Richard Skoien, Visiting Scientist
- Anna Weis, PhD student
- Diego Calvopina, PhD student
- Berit Genz, Visiting scientist
- Gautam Rishi, Affiliate
- Private: Professor Nathan Subramaniam, Group Leader
- Eriza Secondes, Affiliate
- Dr Carolina Soekmadji, Senior Research Officer
- Venkatesh Gavini, PhD Student
The Hepatic Fibrosis laboratory investigates the cellular and molecular mechanisms of liver injury, scar tissue formation (fibrosis) and regeneration in chronic liver disease. If left untreated, uncontrolled fibrosis leads to cirrhosis and liver cancer in adult liver diseases such as haemochromatosis, viral hepatitis and non-alcoholic fatty liver disease, and in children in diseases such as cystic fibrosis and biliary atresia.
- Can we stop the development of bone metastatic prostate cancer?
- Mechanism of inflammation-induced liver scarring (fibrosis) in cirrhosis associated with chronic liver disease
If you wish to apply for QIMR Berghofer's student program,
click here for more information.